Android app on Google Play

Lazard Capital Upgrades Aegerion Pharmaceuticals (AEGR) to Buy

February 11, 2013 6:51 AM EST Send to a Friend
Get Alerts AEGR Hot Sheet
Price: $32.87 --0%

Rating Summary:
    14 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 17 | New: 12
Trade AEGR Now!
Join SI Premium – FREE
Lazard Capital upgraded Aegerion Pharmaceuticals (NASDAQ: AEGR) from Hold to Buy.

For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.

Shares of Aegerion Pharmaceuticals closed at $26.51 yesterday.




You May Also Be Interested In


Related Categories

Upgrades

Related Entities

Lazard

Add Your Comment